Clinical Trials Directory

Trials / Unknown

UnknownNCT01888315

Influence of Catheter-based Renal Denervation in Diseases With Increased Sympathetic Activity

Safety and Efficacy Study Investigating the Effects of Catheter-based Renal Denervation on Different Organ Systems in Patients With Increased Sympathetic Activity

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
1,000 (estimated)
Sponsor
University Hospital, Saarland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is aiming to document the long-term safety and effectiveness of renal denervation in patients with hypertension and other diseases characterized by elevated sympathetic drive. Catheter-based renal denervation will be performed using CE marked, percutaneous, systems.

Detailed description

Inclusion Criteria 1. Individual is 18 years of age. 2. Individual agrees to have all procedures performed, and is competent and willing to provide written, informed consent to participate in the registry. 3. Patient scheduled for renal sympathetic denervation using market-released device. Exclusion Criteria 1. In the eyes of the treating physician, the renal artery anatomy would interfere with safe cannulation of the renal artery or meets local standards for surgical repair. 2. Individual has any serious medical condition, which in the opinion of the treating physician may adversely affect the safety and/or effectiveness of the participant (i.e., patients with clinically significant peripheral vascular disease, abdominal aortic aneurysm, bleeding disorders such as thrombocytopenia, hemophilia, significant anemia, etc.).

Conditions

Interventions

TypeNameDescription
DEVICERenal denervation with Symplicity Flex Medtronic/ArdianRenal denervation using CE-marked devices will be performed according to best medical practice.
DEVICERenal denervation with EnligHTN St. Jude MedicalRenal denervation using CE-marked devices will be performed according to best medical practice.
DEVICERenal denervation with Paradise RecorRenal denervation using CE-marked devices will be performed according to best medical practice.
DEVICERenal denervation with V2 VessixRenal denervation using CE-marked devices will be performed according to best medical practice.

Timeline

Start date
2011-01-01
Primary completion
2021-01-01
Completion
2021-01-01
First posted
2013-06-27
Last updated
2013-06-27

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01888315. Inclusion in this directory is not an endorsement.